137 related articles for article (PubMed ID: 24222130)
1. Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells.
Stope MB; Bradl J; Peters S; Streitbörger A; Weiss M; Zimmermann U; Walther R; Lillig CH; Burchardt M
Anticancer Res; 2013 Nov; 33(11):4921-6. PubMed ID: 24222130
[TBL] [Abstract][Full Text] [Related]
2. Heat-shock protein HSPB1 attenuates microRNA miR-1 expression thereby restoring oncogenic pathways in prostate cancer cells.
Stope MB; Stender C; Schubert T; Peters S; Weiss M; Ziegler P; Zimmermann U; Walther R; Burchardt M
Anticancer Res; 2014 Jul; 34(7):3475-80. PubMed ID: 24982356
[TBL] [Abstract][Full Text] [Related]
3. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
Xiao J; Gong AY; Eischeid AN; Chen D; Deng C; Young CY; Chen XM
Prostate; 2012 Oct; 72(14):1514-22. PubMed ID: 22314666
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R
Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells.
Stope MB; Peters S; Großebrummel H; Zimmermann U; Walther R; Burchardt M
World J Urol; 2015 Mar; 33(3):323-7. PubMed ID: 24798454
[TBL] [Abstract][Full Text] [Related]
7. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
8. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor-mediated repression of novel target genes.
Prescott J; Jariwala U; Jia L; Cogan JP; Barski A; Pregizer S; Shen HC; Arasheben A; Neilson JJ; Frenkel B; Coetzee GA
Prostate; 2007 Sep; 67(13):1371-83. PubMed ID: 17624924
[TBL] [Abstract][Full Text] [Related]
10. miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
Sikand K; Slaibi JE; Singh R; Slane SD; Shukla GC
Int J Cancer; 2011 Aug; 129(4):810-9. PubMed ID: 21710544
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
15. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator.
Jiang CY; Ruan Y; Wang XH; Zhao W; Jiang Q; Jing YF; Han BM; Xia SJ; Zhao FJ
Mol Cell Endocrinol; 2016 May; 427():13-20. PubMed ID: 26940039
[TBL] [Abstract][Full Text] [Related]
16. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
[TBL] [Abstract][Full Text] [Related]
17. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
18. Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27).
Li J; Fu X; Cao S; Li J; Xing S; Li D; Dong Y; Cardin D; Park HW; Mauvais-Jarvis F; Zhang H
J Biol Chem; 2018 Aug; 293(33):12719-12729. PubMed ID: 29934310
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin causes inactivation and degradation of the androgen receptor by inducing the restoration of miR-449a in prostate cancer.
Zheng L; Chen J; Ma Z; Liu W; Yang F; Yang Z; Wang K; Wang X; He D; Li L
Oncol Rep; 2015 Aug; 34(2):1027-34. PubMed ID: 26081756
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
Mashima T; Okabe S; Seimiya H
Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
